Form D · Pharmaceuticals
Z53 Therapeutics, LLC
Cleveland, OH · CIK 0001667634
Offering snapshot reported Mar 2, 2016 · SEC filing
- Reported sold
- $550K Offering amount: $5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 19, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 2, 2016 | Initial | $550,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-258422
Source: Form D, filed Mar 2, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Baiju Shah | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
20600 Chagrin Blvd. Ste 210
Cleveland, OH, 44122
Cleveland, OH, 44122